Plant-based production of highly potent anti-HIV antibodies with engineered posttranslational modifications

Broadly neutralising antibodies (bNAbs) against human immunodeficiency virus type 1 (HIV-1), such as CAP256-VRC26 are being developed for HIV prevention and treatment. These Abs carry a unique but crucial post-translational modification (PTM), namely O-sulfated tyrosine in the heavy chain complement...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Advaita Acarya, Pooe, Ofentse, Kwezi, Lusisizwe, Lotter-Stark, Therese, Stoychev, Stoyan H., Alexandra, Kabamba, Gerber, Isak, Bhiman, Jinal N., Vorster, Juan, Pauly, Michael, Zeitlin, Larry, Whaley, Kevin, Mach, Lukas, Steinkellner, Herta, Morris, Lynn, Tsekoa, Tsepo Lebiletsa, Chikwamba, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148297/
https://www.ncbi.nlm.nih.gov/pubmed/32277089
http://dx.doi.org/10.1038/s41598-020-63052-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148297/
https://www.ncbi.nlm.nih.gov/pubmed/32277089
http://dx.doi.org/10.1038/s41598-020-63052-1

Ejemplares similares